Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Zhizhen Biotechnology (Zhizhen Bio) is a synthetic biology company that has developed an advanced high-throughput protein expression and purification platform. Founded in 2021 and headquartered in Shanghai, the company integrates automation, artificial intelligence, and microfluidics to optimize the production of proteins and antibodies. Their technology significantly reduces the time required for protein discovery and characterization, serving as a critical infrastructure for pharmaceutical R&D and industrial biotechnology. Zhizhen Bio provides 'one-stop' services ranging from sequence design to purified protein delivery, helping partners overcome the protein supply bottleneck in drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Zhizhen Biotechnology.